Agios Pharmaceuticals Incの価格/販売
Agios Pharmaceuticals Incの価格/販売は何ですか。
Agios Pharmaceuticals Incの価格/販売は54.44です。
価格/販売の定義は何ですか。
価格対売上比率は、収益と比較した会社の株価です。
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
NASDAQのセクタHealth Careにおける価格/販売の企業と比べるAgios Pharmaceuticals Inc
Agios Pharmaceuticals Incは何をしますか。
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Agios Pharmaceuticals Incと類似の価格/販売
- Calamos Global Total Return Fundの価格/販売は54.06です。
- 4D pharma plcの価格/販売は54.10です。
- Mesoblast Ltdの価格/販売は54.12です。
- Eagle Capital Growth Fundの価格/販売は54.33です。
- Bluefield Solar Income Fundの価格/販売は54.35です。
- Gensight Biologics SAの価格/販売は54.37です。
- Agios Pharmaceuticals Incの価格/販売は54.44です。
- Invitrocueの価格/販売は54.46です。
- Sanwaria Consumerの価格/販売は54.50です。
- 4SC AGの価格/販売は54.57です。
- Soligenix Incの価格/販売は54.61です。
- The State Trading of Indiaの価格/販売は54.68です。
- Ascentage Pharma Grp Intlの価格/販売は54.83です。